Falk Foundation | Dr. Falk
You are here:  Home
Press releases from recent symposias
Progress on many levels
Hepatologists see bright prospects for the future

Workshop Essen (Germany), January 2017

Essen. In some areas of hepatology, such as the treatment of hepatitis C, there has been enormous progress during the last few years. But hepatology appears to be entering a new era in other fields as well. Other relevant advances in diagnostics and therapy have clearly come within feasible reach for a variety of hepatological disease patterns. More...

Liver and Bowel Diseases: Incorporating Therapeutic Progress into Clinical Routines

Symposium 205, Lucerne (Switzerland), October 2016
Lucerne. Progress is currently being made in treating both chronic liver and chronic bowel disease. This is not only the case for hepatitis C, but now also for cholestatic liver diseases and inflammatory bowel disease (IBD). However, the novel therapy options are now making treatment considerably more complex, highlighted Professor Gerhard Rogler, Zürich... More...

Liver experts are working on new diagnostic and therapeutic tools

Symposium 204, Birmingham (United Kingdom), September 2016
Birmingham. Globally, every year more than 2 million people die from complications of chronic liver disease. Hepatitis, autoimmune diseases, the consequences of overnutrition, and alcohol abuse were the subjects of an international symposium held by the Falk Foundation e.V. in Birmingham/United Kingdom. More...
Symposia Overview

Symposium 204
Clinical Hepatology
Practice in 2016:
From Science to Therapy

(United Kingdom),
September 2 – 3, 2016

  Symposium 206
  From the New and
  Complex Concepts
  to the Real Patient:
  Science and Clinic in IBD
  Madrid (Spain)
  March 31 - April 1, 2017

Video Report
Treating PBC and PSC
Prof. Dr. U. Beuers, Amsterdam,
Symposium 201
Interactions: From